Table 1. Patient clinical characteristics and the final histological diagnoses (n=51).
| Characteristics | Value | ||
|---|---|---|---|
| Age | 66 (57–76) | ||
| Nulliparous | 15 (29) | ||
| Body mass index (kg/m2) | 28.8 (25.6–32.7) | ||
| Time since menopause | 12 (5–27) | ||
| Hypertension | 18 (35) | ||
| Diabetes mellitus | 5 (10) | ||
| Fibroids (total) | 14 (27) | ||
| Fibroids (submucosal) | 1 (2) | ||
| Adenomyosis | 5 (10) | ||
| Endometrial thickness (mm) | 16.5 (11.4–30) | ||
| Tumor mean diameter (mm) | 25 (18–41) | ||
| Final histological diagnoses | |||
| Endometrioid histological subtype | 38 (75) | ||
| Grade 1 | 19 (50) | ||
| Grade 2 | 18 (47) | ||
| Grade 3 | 1 (3) | ||
| Non-endometrioid histological subtype | 13 (25) | ||
| Carcinosarcoma | 5 (38) | ||
| Serous | 4 (31) | ||
| Neuroendocrine | 2 (15) | ||
| Clear cell | 1 (8) | ||
| Mixed serous/Endometrioid | 1 (8) | ||
| FIGO stage of endometrial cancer | |||
| Stage 1a | 25 (49) | ||
| Stage 1b | 11 (22) | ||
| Stage 2 | 4 (8) | ||
| Stage 3a | 2 (4) | ||
| Stage 3b | 3 (6) | ||
| Stage 3c1 | 4 (8) | ||
| Stage 3c2 | 0 (0) | ||
| Stage 4 | 2 (4) | ||
Values are presented as median (interquartile range) or number (%).